Cargando…

Niclosamide Induces Cell Cycle Arrest in G1 Phase in Head and Neck Squamous Cell Carcinoma Through Let-7d/CDC34 Axis

Niclosamide is a traditional anti-tapeworm drug that exhibits potent anti-cancer activity. Our previous study showed that niclosamide induces cell cycle arrest in G1 phase. Nevertheless, the underlying mechanism remains unknown. The following study investigated the molecular mechanism through which...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Zewen, Li, Qingxiang, Wang, Yifei, Wang, Lin, Li, Xiaoxu, Ge, Na, Wang, Yixiang, Guo, Chuanbin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333743/ https://www.ncbi.nlm.nih.gov/pubmed/30687101 http://dx.doi.org/10.3389/fphar.2018.01544

Ejemplares similares

Oral administration of Bifidobacterium breve promotes antitumor efficacy via dendritic cells-derived interleukin 12
por: Li, Qingxiang, et al.
Publicado: (2021)

Exopolysaccharide, Isolated From a Novel Strain Bifidobacterium breve lw01 Possess an Anticancer Effect on Head and Neck Cancer – Genetic and Biochemical Evidences
por: Wang, Lin, et al.
Publicado: (2019)

MicroRNA let-7c Inhibits Cell Proliferation and Induces Cell Cycle Arrest by Targeting CDC25A in Human Hepatocellular Carcinoma
por: Zhu, Xiuming, et al.
Publicado: (2015)

P2RY14 Is a Potential Biomarker of Tumor Microenvironment Immunomodulation and Favorable Prognosis in Patients With Head and Neck Cancer
por: Li, Qingxiang, et al.
Publicado: (2021)

The magic bullet: Niclosamide
por: Jiang, Haowen, et al.
Publicado: (2022)

Niclosamide: Beyond an antihelminthic drug
por: Chen, Wei, et al.
Publicado: (2018)

Inhibition of STAT3 by Niclosamide Synergizes with Erlotinib against Head and Neck Cancer
por: Li, Rui, et al.
Publicado: (2013)

Retraction: MicroRNA let-7c Inhibits Cell Proliferation and Induces Cell Cycle Arrest by Targeting CDC25A in Human Hepatocellular Carcinoma
Publicado: (2023)

pERK-mediated IL8 secretion can enhance the migration, invasion, and cisplatin resistance of CD10-positive oral cancer cells
por: Pu, Yinfei, et al.
Publicado: (2021)

Bone morphogenetic protein receptor 1α promotes osteolytic lesion of oral squamous cell carcinoma by SHH‐dependent osteoclastogenesis
por: Qiao, Qiao, et al.
Publicado: (2022)

Antihelminthic niclosamide modulates dendritic cells activation and function
por: Wu, Chieh-Shan, et al.
Publicado: (2014)

Antitumor effect and metabonomics of niclosamide micelles
por: Hang, Jiarong, et al.
Publicado: (2022)

A Dual-Specificity Phosphatase Cdc25B Is an Unstable Protein and Triggers p34(cdc2)/Cyclin B Activation in Hamster BHK21 Cells Arrested with Hydroxyurea
por: Nishijima, Hitoshi, et al.
Publicado: (1997)

Synthesis and biological evaluation of niclosamide PROTACs
por: Munoz, Erick, et al.
Publicado: (2022)

Niclosamide is a potential candidate for the treatment of chemo-resistant osteosarcoma
por: Huang, Xiaoling, et al.
Publicado: (2023)

Suppression of G6PD induces the expression and bisecting GlcNAc-branched N-glycosylation of E-Cadherin to block epithelial-mesenchymal transition and lymphatic metastasis
por: Wang, Yifei, et al.
Publicado: (2020)

Niclosamide suppresses Hepatoma cell proliferation via the Wnt pathway
por: Tomizawa, Minoru, et al.
Publicado: (2013)

Drug Screening Identifies Niclosamide as an Inhibitor of Breast Cancer Stem-Like Cells
por: Wang, Yu-Chi, et al.
Publicado: (2013)

Low doses of niclosamide and quinacrine combination yields synergistic effect in melanoma via activating autophagy-mediated p53-dependent apoptosis
por: Zheng, Xuan, et al.
Publicado: (2022)

Porphyromonas, Treponema, and Mogibacterium promote IL8/IFNγ/TNFα-based pro-inflammation in patients with medication-related osteonecrosis of the jaw
por: Li, Qingxiang, et al.
Publicado: (2020)

Systematic identification of CDC34 that functions to stabilize EGFR and promote lung carcinogenesis
por: Zhao, Xin-Chun, et al.
Publicado: (2020)

Binding interactions of niclosamide with serum proteins
por: Maltas, Esra
Publicado: (2014)

Niclosamide for Covid-19: bridging the gap
por: Al-kuraishy, Hayder M., et al.
Publicado: (2021)

Repurposing niclosamide for the treatment of neurological disorders
por: Apolloni, Savina, et al.
Publicado: (2023)

Desolvation Processes in Channel Solvates of Niclosamide
por: Mann, Jen E., et al.
Publicado: (2023)

Sensitivity of Oncomelania hupensis to Niclosamide: A Nation-Wide Survey in China
por: Dai, Jianrong, et al.
Publicado: (2014)

Interaction Behavior Between Niclosamide and Pepsin Determined by Spectroscopic and Docking Methods
por: Guo, Liuqi, et al.
Publicado: (2015)

Niclosamide induced cell apoptosis via upregulation of ATF3 and activation of PERK in Hepatocellular carcinoma cells
por: Weng, Shunyan, et al.
Publicado: (2016)

Selectively Targeting Breast Cancer Stem Cells by 8-Quinolinol and Niclosamide
por: Cámara-Sánchez, Patricia, et al.
Publicado: (2022)

Niclosamide suppresses T-cell acute lymphoblastic leukemia growth through activation of apoptosis and autophagy
por: Huang, Fang-Liang, et al.
Publicado: (2022)

The Anthelmintic Drug Niclosamide Induces Apoptosis, Impairs Metastasis and Reduces Immunosuppressive Cells in Breast Cancer Model
por: Ye, Tinghong, et al.
Publicado: (2014)

Let-7a inhibits proliferation and promotes apoptosis of human asthmatic airway smooth muscle cells
por: Chen, Yan, et al.
Publicado: (2019)

Microtubule dependency of p34cdc2 inactivation and mitotic exit in mammalian cells
Publicado: (1994)

Niclosamide as a Promising Therapeutic Player in Human Cancer and Other Diseases
por: Wang, Zhan, et al.
Publicado: (2022)

Niclosamide inhibits the cell proliferation and enhances the responsiveness of esophageal cancer cells to chemotherapeutic agents
por: Lee, Ming-Cheng, et al.
Publicado: (2020)

Niclosamide Inhibits Cell Growth and Enhances Drug Sensitivity of Hepatocellular Carcinoma Cells via STAT3 Signaling Pathway
por: Wang, Chengzhi, et al.
Publicado: (2018)

Prp19 Arrests Cell Cycle via Cdc5L in Hepatocellular Carcinoma Cells
por: Huang, Renzheng, et al.
Publicado: (2017)

Repurposing Niclosamide for Targeting Pancreatic Cancer by Inhibiting Hh/Gli Non-Canonical Axis of Gsk3β
por: Kaushal, Jyoti B., et al.
Publicado: (2021)

Niclosamide (NA) overcomes cisplatin resistance in human ovarian cancer
por: Huang, Linjuan, et al.
Publicado: (2023)

Niclosamide Triggers Non-Canonical LC3 Lipidation
por: Liu, Yajun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8fmi4jit4vj4uk246hmdl2nael